
Neovasc NVCN
Geschäftsbericht 2021
hinzugefügt 23.12.2023
Neovasc P/CF 2011-2026 | NVCN
P/CF Jährlich Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -25 | -6.58 | -21.2 | -11.3 | -8.09 | -2.13 | -12.6 | -55.8 | -36 | -42.8 | -25 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.13 | -55.8 | -22.4 |
P/CF anderer Aktien in der Medizinische Geräte
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
18.9 | $ 186.04 | 0.73 % | $ 13.9 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
2 | $ 12.66 | -0.9 % | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
17.2 | $ 296.5 | 1.38 % | $ 8.37 B | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.45 | 4.39 % | $ 129 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 39.67 | -0.56 % | $ 5.91 K | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 64.31 | 0.78 % | $ 95.2 B | ||
|
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.6 | 1.34 % | $ 37.3 M | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 1.95 | -1.52 % | $ 1.19 M | ||
|
ClearPoint Neuro
CLPT
|
-13.2 | $ 10.47 | 0.87 % | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
15.3 | $ 25.72 | 2.02 % | $ 217 M | ||
|
Inogen
INGN
|
-14.3 | $ 6.29 | -0.79 % | $ 167 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.03 | -0.1 % | $ 17.4 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
LENSAR
LNSR
|
-4.81 | $ 6.17 | 2.15 % | $ 73.8 M | ||
|
Globus Medical
GMED
|
16.6 | $ 94.65 | -0.29 % | $ 12.8 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 18.25 | 2.18 % | $ 428 M | ||
|
Butterfly Network
BFLY
|
-18.4 | $ 4.78 | 7.91 % | $ 1.01 B | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Myomo
MYO
|
-2.34 | $ 0.79 | 0.09 % | $ 33.1 M | ||
|
Delcath Systems
DCTH
|
14.5 | $ 10.91 | 0.28 % | $ 391 M | ||
|
Inspire Medical Systems
INSP
|
15.1 | $ 57.62 | 1.34 % | $ 1.69 B | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 39.3 | -1.11 % | $ 1.22 B | ||
|
LivaNova PLC
LIVN
|
15 | $ 65.53 | 0.83 % | $ 3.57 B | ||
|
Integer Holdings Corporation
ITGR
|
15.2 | $ 87.32 | -1.46 % | $ 3.03 B | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.75 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
30.6 | $ 78.01 | -0.24 % | $ 45.6 B | ||
|
NanoVibronix
NAOV
|
-0.366 | - | - | $ 1.08 M |